- Home
- RLAY vs GLDD Comparison
RLAY vs GLDD Comparison
Compare RLAY & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- GLDD
- Stock Information
- Founded
- RLAY 2015
- GLDD 1890
- Country
- RLAY United States
- GLDD United States
- Employees
- RLAY N/A
- GLDD N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- GLDD Military/Government/Technical
- Sector
- RLAY Health Care
- GLDD Industrials
- Exchange
- RLAY Nasdaq
- GLDD Nasdaq
- Market Cap
- RLAY 620.4M
- GLDD 516.1M
- IPO Year
- RLAY 2020
- GLDD 2006
- Fundamental
- Price
- RLAY $2.62
- GLDD $8.70
- Analyst Decision
- RLAY Strong Buy
- GLDD Buy
- Analyst Count
- RLAY 10
- GLDD 1
- Target Price
- RLAY $19.33
- GLDD $14.00
- AVG Volume (30 Days)
- RLAY 2.5M
- GLDD 432.5K
- Earning Date
- RLAY 05-01-2025
- GLDD 05-06-2025
- Dividend Yield
- RLAY N/A
- GLDD N/A
- EPS Growth
- RLAY N/A
- GLDD 301.51
- EPS
- RLAY N/A
- GLDD 0.84
- Revenue
- RLAY $10,007,000.00
- GLDD $762,693,000.00
- Revenue This Year
- RLAY N/A
- GLDD $3.81
- Revenue Next Year
- RLAY $544.28
- GLDD $11.69
- P/E Ratio
- RLAY N/A
- GLDD $10.52
- Revenue Growth
- RLAY N/A
- GLDD 29.35
- 52 Week Low
- RLAY $2.45
- GLDD $6.55
- 52 Week High
- RLAY $10.72
- GLDD $12.89
- Technical
- Relative Strength Index (RSI)
- RLAY 32.07
- GLDD 44.86
- Support Level
- RLAY $3.05
- GLDD $8.78
- Resistance Level
- RLAY $3.08
- GLDD $9.36
- Average True Range (ATR)
- RLAY 0.25
- GLDD 0.30
- MACD
- RLAY -0.04
- GLDD 0.11
- Stochastic Oscillator
- RLAY 11.64
- GLDD 58.05
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.